Cancer Institute (WIA)

What Cancer Institute (WIA) does

Cancer Institute (WIA), founded in 1954 in Chennai, India, is a public charitable not-for-profit comprehensive cancer center registered under the Societies Registration Act of 1860. It operates as the first comprehensive cancer center in South India and the second in the country, with 675+ patient care beds across two Adyar campuses and a free hospice at Sriperumbudur. The institute serves approximately 15,000 new patients and 160,000 follow-up patients annually through outpatient departments, inpatient services, and community outreach screening programs across 9 districts of Tamil Nadu. Patients are treated regardless of socioeconomic status, with a significant share receiving free or heavily subsidized care under the institute's "Service to All" ethos.

The institute runs an integrated multi-modality oncology platform combining radiation oncology (linear accelerators, Cobalt-60, IORT, brachytherapy, Rapid Arc therapy, SBRT, True Beam), medical oncology (chemotherapy, targeted therapy, immunotherapy, stem cell transplantation), and surgical oncology (including Da Vinci robotic surgery, limb salvage, HIPEC). It operates dedicated diagnostic departments in radiology, microbiology, clinical biochemistry, oncopathology, and molecular oncology — the latter equipped with NGS, MALDI TOF, and mass spectrometry infrastructure. It also runs the Tamil Nadu Cancer Registry Project (covering 78-80 million population, the largest in the world), a hereditary cancer detection program (first in India, 2002), a pediatric oncology ward (55 beds), palliative care, psycho-oncology, and rehabilitation services.

The business model combines charitable free/subsidized treatment, paid services for patients who can afford them, CMCHIS (state government insurance scheme) reimbursements, and research grants from ICMR, IARC, DBT, Wellcome Trust, and other agencies. Revenue is not publicly disclosed. Leadership comprises Chairman N.L. Rajah, Vice Chairman Dr. E. Hemanth Raj, CEO & Director Dr. Kalpana Balakrishnan, and CFO & Secretary Shri V. Venugopal. The institute is NABH accredited (since July 2019) and serves as a teaching hospital offering DM Medical Oncology, M.Ch Surgical Oncology, MD Radiation Oncology, Ph.D., and allied health science programs, having trained over 100 M.Ch Surgical Oncologists who now head departments across India.

Name

Cancer Institute (WIA)

Legal name

Cancer Institute (WIA)

Website

https://cancerinstitutewia.in

Company type

Private

Founded year

1954

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Cancer Institute (WIA) is a charitable not-for-profit comprehensive cancer center founded in 1954 in Chennai, India, operating 675+ beds and serving 175,000+ patients annually through multi-modality oncology services spanning prevention, diagnosis, treatment, research, and palliative care.

Ownership category

akta.pro rank

Product category

Cancer Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Cancer treatment services
• Oncology care
• Radiation therapy
• Surgical oncology
• Cancer diagnostics

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Charitable Care and Subsidized Treatment: Cancer Institute (WIA) is a public charitable voluntary not-for-profit institution. The institute provides free or subsidized treatment to a significant number of patients who cannot afford cancer care. Treatment is provided irrespective of social or economic status.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

Cancer Institute (WIA) is a charitable comprehensive cancer center providing the full continuum of oncology services from prevention and screening through diagnosis, multi-modality treatment (radiation, medical, surgical, and pediatric oncology), rehabilitation, and palliative care. Operating across two campuses in Chennai with over 675 patient care beds, the institute also runs clinical research, population-based cancer registry programs, and oncology education and training, while delivering free or subsidized treatment to economically disadvantaged patients.

Product overview

Cancer Institute (WIA) operates as a comprehensive cancer center offering a full spectrum of oncology services from prevention to palliative care. The institute functions as an integrated platform combining diagnostic services (radiology, pathology, microbiology, biochemistry, molecular diagnostics), therapeutic services (radiation oncology, medical oncology, surgical oncology, pediatric oncology), and supportive care (psycho-oncology, palliative care, physiotherapy). Additional offerings include clinical research services, cancer registry programs, and medical education/training. The institute provides approximately 15,000 new patients and 160,000 follow-up patients annually with over 675 patient care beds across two campuses in Chennai.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• More than 95% of patients presenting with early stage cancer at the institute live longer with good quality of life than others
• +6 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

13 partnerships are on record, tiered core, major and minor.

• Various Trusts for Pediatric OncologycoreStrategic or Co-development Partner · 1 January 2025Organizations including MAHESH MEMORIAL TRUST, JEEVADAYA TRUST, and CAN KIDS are actively involved in supporting the pediatric ward activities providing holistic care including medical treatment, psycho-social support, nutritional support, education, and play therapy.
• Singhvi Charitable Trust (led by Shri Sugal Chand Jain)coreStrategic or Co-development Partner · 1 January 2017Singhvi Charitable Trust contributed to establishing Mahaveer Ashray, a totally free hospice providing accommodation, food, and treatment for cancer patients in need of end-of-life care.
• The Tamil Nadu Dr. M.G.R. Medical UniversitycoreStrategic or Co-development Partner · 1 January 2013Affiliation for MD Radiation Oncology, DM Medical Oncology, M.Ch Surgical Oncology, Ph.D. Oncology degrees.
• Department of Health and Family Welfare, Government of Tamil NadumajorStrategic or Co-development Partner · 1 January 2012Tamil Nadu Cancer Registry Project (TNCRP) - Joint project of Cancer Institute (WIA) and Department of Health and Family Welfare, Government of Tamil Nadu covering 80 million population, the largest cancer registry in the world.
• International Agency for Research on Cancer (IARC)majorStrategic or Co-development Partner · 1 January 2003IARC project on Dindigul Ambilikkai Cancer Registry (DACR) addressing paucity of rural cancer data and providing framework for evaluating cervix cancer field intervention trial in Dindigul district.
• Indian Council of Medical Research (ICMR)majorStrategic or Co-development Partner · 1 January 1981ICMR partially funds the Madras Metropolitan Tumour Registry (MMTR) since 1981, Hospital Cancer Registry (HCR) since 1984, and various research projects including Patterns of Care and Survival studies. ICMR project on HPV and Oral cancer (DBT India Alliance and Wellcome Trust funded, 1.8 crores for five years 2019-2024).
• AECL CanadaminorOthers · 1 January 1956Gift of AECL, Canada - 60 Co teletherapy unit installed in 1956, introducing the super-voltage era in the whole of Asia including Japan and Australia.
• HCL FoundationcoreStrategic or Co-development PartnerHCL Foundation supports cancer patients at the institute through provision of wigs for chemotherapy patients experiencing hair loss and breast prosthesis for mastectomy patients. This support enables patients to maintain confidence and quality of life during and after treatment.
• NABARDminorStrategic or Co-development PartnerNABARD supports wig making as an alternative livelihood program for women previously engaged in beedi rolling, providing sustainable income opportunities for marginalized communities served by the institute.
• Anna UniversitycoreStrategic or Co-development PartnerAffiliation for M.Sc (Medical Physics) course (since 1981) and Ph.D. Oncology & Medical Physics.
• University of MadrascoreStrategic or Co-development PartnerAffiliation for Ph.D. Oncology degree.
• National Board of Examinations in Medical SciencescoreStrategic or Co-development PartnerAffiliation for D.N.B. Palliative Medicine, D.N.B. Radio-Diagnosis, F.N.B. Onco-Anaesthesia, F.N.B. Breast-Imaging, F.N.B. Onco-Imaging programs.
• Indian College of Radiology & ImagingminorStrategic or Co-development PartnerAffiliation for Fellowship in Onco-Imaging and Fellowship in Breast-Imaging programs.

Scale indicators23 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• Fortis Memorial Research Institute (Oncology): Private multi-specialty hospital group with oncology services including bone marrow transplant and robotic surgery. Comparable as a broad incumbent; competes with WIA for paying patients seeking advanced private-sector cancer care, but is not a dedicated cancer hospital.
• Max Healthcare (Cancer Care): Large North-India private hospital chain with significant oncology programmes across Delhi-NCR and other metros. Comparable as a broad incumbent offering radiation, medical and surgical oncology alongside other specialties; less direct overlap with WIA's regional/single-city focus.
• Apollo Hospitals (Cancer / Oncology Programme): India's largest private multi-specialty hospital chain, with comprehensive cancer centres across major cities. Comparable as a broad incumbent offering radiation, medical and surgical oncology within a larger multi-specialty portfolio — competes with WIA for complex oncology cases but does not specialise solely in cancer.
• Mazumdar Shaw Medical Centre (Narayana Health): Bengaluru-based tertiary cancer hospital within the Narayana Health network. Comparable as a comprehensive oncology provider offering multi-modality treatment and research — overlaps with WIA's service lines but operates as part of a broader multi-specialty group.

Direct peers

• HealthCare Global Enterprises (HCG): India's largest private dedicated oncology hospital network, headquartered in Bengaluru. Direct comparable: pan-India operator of comprehensive cancer centres offering radiation, medical and surgical oncology with a strong technology focus (linear accelerators, robotic surgery, molecular diagnostics) — same specialty vertical as WIA, but private-equity-backed and national in scope.
• Regional Cancer Centre (RCC), Thiruvananthapuram: Kerala's autonomous comprehensive cancer centre established in 1981. Direct comparable: state-level public cancer centre with research (CRC), teaching, and multi-modality treatment — parallel model to WIA in terms of public-sector mandate, scale, and South-Indian operating context.
• Tata Memorial Hospital (Tata Memorial Centre): India's oldest and largest dedicated cancer hospital, located in Mumbai. Direct comparable: public-sector, comprehensive cancer centre providing multi-modality treatment, research (ACTREC), and training across the full oncology continuum — same operating model and patient population as Cancer Institute (WIA), but at a national rather than regional scale.
• Kidwai Memorial Institute of Oncology: State-run comprehensive cancer centre in Bengaluru, Karnataka, established in 1980. Direct comparable: autonomous government cancer hospital providing radiation, medical and surgical oncology with research and training, serving a regional population in South India — similar to WIA's Tamil Nadu footprint and public-charitable character.
• AIIMS, New Delhi (Cancer Centre / IRCH): Dr. B.R.A. Institute-Rotary Cancer Hospital (IRCH) at AIIMS Delhi is a public comprehensive cancer centre with research and training. Comparable in mandate and operating model to WIA, with similar specialty-hospital focus and government/teaching hospital context but at a national referral level.

Emerging players

• American Oncology Institute (CTRI): Network of dedicated cancer centres across Tier-2/3 Indian cities with multi-modality oncology care. Comparable as an emerging private oncology specialist; partial overlap with WIA's specialty focus but smaller per-city scale and less research depth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Cancerinstitutewiaadyarchennai
• LinkedInlinkedin.com/company/cancer-institute-adyar

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Institute (WIA)